China Pharma (CPHI) News Today $1.74 -0.07 (-3.59%) Closing price 03:59 PM EasternExtended Trading$1.79 +0.04 (+2.58%) As of 06:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock CPHI Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period CPHI China Pharma Holdings, Inc. - Seeking AlphaJune 25, 2025 | seekingalpha.comChina is catching up to the U.S. in pharmaceuticals, but it’s not too late to turn that aroundJune 17, 2025 | msn.comFocus: US pharma bets big on China to snap up potential blockbuster drugsJune 16, 2025 | reuters.comPfizer in deal with China's 3SBio to license cancer drug candidate, take equity stakeMay 20, 2025 | msn.comPharma stocks erase early losses driven by Trump's plans to cut drug pricesMay 13, 2025 | businessinsider.comAmCham China President Says Pharma Companies Have Reported Tariff Exemptions on China ImportsApril 25, 2025 | msn.comChina Pharma announces 1-for-10 reverse stock splitApril 5, 2025 | markets.businessinsider.comThe US relies on China for key medicines. They won’t be spared from tariffsFebruary 9, 2025 | msn.comChina Pharma Holdings, Inc.January 26, 2025 | seekingalpha.comChina Pharma Holdings, Inc. Completes Full Redemptions Under Convertible Note Agreement with StreetervilleDecember 18, 2024 | prnewswire.comChina Pharma Announces the Entry of "At-The-Market" Equity OfferingDecember 13, 2024 | prnewswire.comRoche Will Boost In-China Production for Local Market, CEO SaysOctober 9, 2024 | bloomberg.comSamsung Biologics eyes expansion amid US bio firms' decoupling from ChinaOctober 7, 2024 | msn.comChina's WuXi explores sale of pharma units as US restrictions loom, FT reportsOctober 3, 2024 | yahoo.comChina's WuXi explores sale of pharma operations as US restrictions loom, FT reportsOctober 3, 2024 | msn.comRegeneron, Sanofi Say Dupixent Approved In China To Treat Chronic Obstructive Pulmonary DiseaseSeptember 27, 2024 | markets.businessinsider.comChina Medical System: New Drug Application for Vitiligo Indication of Ruxolitinib Phosphate Cream Accepted in ChinaSeptember 25, 2024 | markets.businessinsider.comAcceleration in China+1 trend in Pharmaceuticals sector!August 31, 2024 | msn.comUS pharmaceutical companies ran drug trials with Chinese military for more than a decade, House committee revealsAugust 20, 2024 | msn.comChina Pharma Plans To Launch Dry Eye Disease Therapeutic Device In China - Quick FactsAugust 19, 2024 | markets.businessinsider.comChina Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025August 19, 2024 | prnewswire.comPharmaceutical Excipients Market Size Expected to Reach USD 14.72 Bn by 2033August 7, 2024 | finance.yahoo.comQuantum pipeline unveiled in China could transform future of drug designingJuly 28, 2024 | msn.comDrug giants eye China for deals despite growing Sino-US tensionsJuly 22, 2024 | reuters.comChina's Philippines embassy demands answers for propaganda against COVID vaccineJuly 22, 2024 | reuters.comTianjin Pharma Announces Upcoming Investor BriefingMay 28, 2024 | nasdaq.comPhotocure : Asieris' NDA For Cevira Accepted By NMPA For Regulatory Review In ChinaMay 12, 2024 | markets.businessinsider.comChina Pharma Holding Inc CPHIMay 4, 2024 | morningstar.comMChina Pharma Holding IncMarch 22, 2024 | morningstar.comMChina Healthcare Stocks Rally on Hopes for Govt SupportMarch 14, 2024 | msn.comChina Healthcare Stocks Rally on Hopes for Govt SupportMarch 14, 2024 | msn.comRising Demand for Secure Packaging Solutions and Enhanced Aesthetic Appeal Propels Market to US$ 432.1M by 2034 | Future Market Insights, Inc.March 11, 2024 | tmcnet.comChina Pharma Holdings, Inc. (CPHI)March 6, 2024 | finance.yahoo.comChina Pharma Holding Stock (AMEX:CPHI), Insider Trading ActivityFebruary 27, 2024 | benzinga.comChina Pharma Holding Stock (AMEX:CPHI), Guidance and ForecastFebruary 27, 2024 | benzinga.comChina Pharma Holdings, Inc.: China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock SplitFebruary 24, 2024 | finanznachrichten.deChina Pharma Holdings Inc. Announces 1-for-5 Reverse Stock SplitFebruary 23, 2024 | prnewswire.comChina Pharma Holdings Issues 15M Unregistered SharesFebruary 9, 2024 | markets.businessinsider.comChina Pharma Holdings Acquires Psoriasis Patent and Profit DealFebruary 9, 2024 | msn.comScoop: China panel plans biotech field hearingFebruary 6, 2024 | msn.comExclusive: China panel eyes biotech field hearingFebruary 6, 2024 | axios.comAChina SXT Pharmaceuticals Inc (SXTC)January 23, 2024 | investing.comChina Pharma Holdings Inc.January 23, 2024 | wsj.comChina’s new cancer drug is approved in the US but will cost 30 times moreNovember 29, 2023 | msn.comChina Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic DeviceNovember 29, 2023 | finance.yahoo.comChina Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic DeviceNovember 29, 2023 | finance.yahoo.comAnother top executive is being investigated by China’s corruption watchdogNovember 21, 2023 | msn.comCASI PHARMACEUTICALS ANNOUNCES MARKET APPROVAL OF CNCT19 BY CHINA NMPANovember 8, 2023 | markets.businessinsider.comKexing Biopharm Attended CPHI Worldwide 2023November 7, 2023 | markets.businessinsider.comXinhua Silk Road: 54th Zhangshu National Traditional Chinese Materia Medica Trade Fair kicks off in E. China's JiangxiNovember 2, 2023 | markets.businessinsider.com Get China Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CPHI and its competitors with MarketBeat's FREE daily newsletter. Email Address CPHI Media Mentions By Week CPHI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CPHI News Sentiment▼0.230.90▲Average Medical News Sentiment CPHI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CPHI Articles This Week▼00▲CPHI Articles Average Week Get China Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CPHI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies DURECT News Today Lisata Therapeutics News Today Briacell Therap News Today MIRA Pharmaceuticals News Today Natural Alternatives International News Today Sol-Gel Technologies News Today BioVie News Today Q32 Bio News Today Mannatech News Today Carisma Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:CPHI) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredSomething very strange is happening...What a "Mar-a-Lago Accord" could mean for the U.S. dollar While protests dominate the news... hardly anyone...Stansberry Research | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China Pharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share China Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
